摘要
目的探讨细胞增殖核抗原Ki-67与环氧合酶2(COX-2)在结直肠癌组织中的表达水平及意义。方法选取我院收治的120例结直肠癌患者为研究对象,采用免疫组织化学法检测患者结直肠癌组织及癌旁组织中的Ki-67与COX-2的阳性表达率,分析Ki-67与COX-2与结直肠癌临床病理特征和预后的关系及结直肠癌组织中Ki-67和COX-2表达的相关性。结果结直肠癌组织、存在淋巴结转移、TNM分期Ⅲ期+Ⅳ期患者中的Ki-67及COX-2阳性表达率显著高于结直肠癌旁组织、不存在淋巴转移、TNM分期Ⅰ期+Ⅱ期的患者(P<0.05)。结直肠癌组织中Ki-67和COX-2表达呈正相关(r=0.571,P<0.05)。Ki-67阳性组和阴性组的5年生存率分别为62.07%、76.36%,COX-2阳性组和阴性组的5年生存率分别为53.26%、68.29%,差异具有统计学意义(P<0.05)。结论 Ki-67与COX-2在结直肠癌组织中表达增高,其阳性表达参与肿瘤形成、发展及转移,且表达水平与患者不良预后相关。
Objective To investigate the expression levels of nuclcar-associated antigen Ki-67 and cyclooxygenase-2(COX-2) in colorectal carcinoma and their significance. Methods A total of 120 colorectal carcinoma patients treated inour hospital were selected as the study objects. The positive expression rates of Ki-67 and COX-2 in colorectal carcinomatissue and carcinoma adjacent tissues in all the patients were detected by immunohistochemical method. The relationshipbetween Ki-67, COX-2 and clinicopathological features, prognosis of colorectal carcinoma and the correlation between Ki-67 and COX-2 expression in colorectal carcinoma were analyzed. Results The positive expression rates of Ki-67 and COX-2in colorectal carcinoma tissues and patients with lymph node metastasis, TNM stage Ⅲ+Ⅳ were higher than those incolorectal carcinoma adjacent tissues and patients without lymph node metastasis, TNM stage Ⅰ+Ⅱ(P〈0.05). Positivecorrelation showed between Ki-67 and COX-2 expression in colorectal carcinoma (r=0.571, P〈0.05). The 5 year survivalrates of Ki-67 positive group and negative group were 62.07%, 76.36% respectively, and that of COX-2 positive group andnegative group were 53.26%, 68.29% respectively, the differences were statistically significant (P〈0.05). Conclusion Theexpression of Ki-67 and COX-2 increase in colorectal cancer tissues, and their positive expression are involved in tumorformation, development and metastasis, and the expression levels are related to the poor prognosis of the patients.
作者
宋涛
SONG Tao(the Second Affiliated Hospital of Xi'an Medical University,Xi'an 710038,China)
出处
《临床医学研究与实践》
2018年第22期11-13,共3页
Clinical Research and Practice